Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 November 1997 | Volume 127 Issue 9 | Pages 817-819
Background: Screening for microalbuminuria is increasingly advocated as a way to diagnose early renal involvement in diabetes and other diseases. It usually entails the use of a radioimmunoassay that is expensive and not always readily available.
Objective: To assess the efficacy of three simple and inexpensive tests for ruling out microalbuminuria.
Design: Cross-sectional study.
Setting: Outpatient clinics.
Patients: 221 patients from primary care clinics and a diabetes clinic.
Measurements: Random urine specimens were tested for albumin by using Micral-Test immunoassay strips (Boehringer Mannheim, Mannheim, Germany) and for protein by using sulfosalicylic acid testing and impregnated dipsticks (Chemstrips, Boehringer Mannheim). Radioimmunoassay for albumin was used for all specimens as standard for comparison.
Results: When less than 20 mg/L was considered the upper limit of normal for albumin concentration, Micral-Test, sulfosalicylic acid testing, and Chemstrips had negative predictive values of 99%, 95%, and 96%, respectively. Seventy-four specimens tested negative on both sulfosalicylic acid and Chemstrips; the negative predictive value of these two tests combined was 99%.
Conclusions: The combination of sulfosalicylic acid testing and Chemstrips was as good as and less expensive than Micral-Test in ruling out microalbuminuria.
The Micral-Test immunoassay (Boehringer Mannheim, Mannheim, Germany) is based on the color shift of a monoclonal antibody (IgG) to human albumin labeled with colloidal gold, a shift that occurs after IgG binds with urinary albumin. The results of this assay were read in a semiquantitative manner as 0 mg/L, 20 mg/L, 50 mg/L, or 100 mg/L. A reading of 0 mg/L was interpreted as negative, and a reading of 20 mg/L or more was considered positive, according to the manufacturer's recommendations.
In the urine protein precipitation test with sulfosalicylic acid, five drops of 20% sulfosalicylic acid were added to 3 mL of urine in one test tube; that tube was compared with a tube of untreated urine held against a dark background. Tubes were observed immediately after the addition of sulfosalicylic acid, and turbidity was taken to indicate proteinuria.
Chemically impregnated dipsticks (Chemstrips, Boehringer Mannheim) were used according to the manufacturer's instructions. Results were recorded as negative, trace, or 1+ positive.
The results were analyzed by using Microsoft Excel software (Microsoft Corp., Redmond, Washington), and statistical measures were calculated in the standard manner. BRIEF COMMUNICATION
Simplified Screening for Microalbuminuria
The early detection of mildly elevated levels of urinary albumin, or microalbuminuria, has been widely advocated as a means of diagnosing and treating early renal involvement in diabetes and several other conditions [1, 2]. However, early detection requires use of a radioimmunoassay that is expensive and not always readily available, making it difficult to test large numbers of patients. These considerations have given rise to the impetus to perform screening by simpler methods, thereby saving cost and time [3-9]. We evaluated three such methods and suggest an approach that should make screening for microalbuminuria practical and affordable in large populations.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
We tested 221 urine specimens obtained from the outpatient laboratory of a general hospital. The specimens had been randomly collected from primary care clinics and from a diabetes clinic that routinely sends urine specimens for all patients to the laboratory. Specimens from a renal clinic were not eligible for the study. Most specimens were early-morning samples with a specific gravity greater than 1015 in 168. Albumin in all samples was measured by radioimmunoassay done using 125I-labeled crystalline human albumin and antihuman albumin, as described elsewhere [10]. Three screening tests were evaluated.
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
We used an upper limit of normal of less than 20 mg/L for the urinary albumin concentration [11]. In a concentrated urine sample, this corresponds roughly to an albumin excretion rate of 30 mg/d [12]. Our results, shown in the Table 1, indicate that a negative Micral-Test reading had a negative predictive value of 99%, a negative sulfosalicylic acid test result had a negative predictive value of 95%, and a negative result on Chemstrips had a negative predictive value of 96%. Seventy-four urine specimens tested negative on both sulfosalicylic acid testing and Chemstrips; on radioimmunoassay, 73 of these specimens were confirmed to be negative. Thus, the combination of a negative sulfosalicylic acid test result and a negative result on Chemstrips virtually ruled out microalbuminuria.
|
However, all three screening tests yielded high rates of false-positive results on a single testing. The positive predictive values were 21% with Micral-Test, 33% with sulfosalicylic acid testing, 19% with Chemstrips, and 34% with the combination of Chemstrips and sulfosalicylic acid testing. This indicates the need to repeatedly test specimens that have positive results and proceed to radioimmunoassay if necessary.
Discussion
|
|---|
|
|
|---|
Sulfosalicylic acid testing was previously found to be sensitive to a protein concentration of 20 to 100 mg/L [17]. It also had a very high negative predictive value (95%), so that a negative result on this test alone rules out most cases of microalbuminuria. We were also surprised by the excellent negative predictive value of Chemstrips, particularly because they have not been advocated for screening for microalbuminuria [18]. In fact, some investigators have used negative results on Chemstrips testing to select patients for studies of microalbuminuria [19]. In our study, a negative result on Chemstrips virtually ruled out microalbuminuria. Anecdotally, we observed that many physicians had difficulty interpreting a "trace" as positive because they had difficulty distinguishing its green color from that of a 1+ positive test result. We further found that combining sulfosalicylic acid testing and Chemstrips was particularly informative; negative results on both tests almost excluded microalbuminuria. Such combination testing is also consonant with the old teaching that testing for albuminuria or proteinuria should be done by two different methods, each confirming the other and thereby eliminating spurious results [17].
In our study, the prevalence of proteinuria was high because the specimens were obtained from primary care clinics and a diabetes clinic. Predictive values clearly depend on the population being tested: A negative predictive value in our set of specimens constitutes a more rigorous evaluation of the test than if the test were to be performed in specimens from a normal population. Unfortunately, we were unable to compare test performance in diabetic and nondiabetic patients.
Our findings have considerable economic implications because hundreds of thousands of patients with diabetes and perhaps other diseases, such as essential hypertension and AIDS, need to be tested. Although we do not rule out a role for the Micral-Test strips, we wish to emphasize that Chemstrips and sulfosalicylic acid testing are inexpensive. A negative result on both tests rules out microalbuminuria, and the tests can be repeated as necessary. In the laboratory, the tests can be done quickly and inexpensively and can even be automated. In the office, the tests can be easily done by the physician, an activity that would be consonant with the traditional view that urinalysis is part of the physical examination. Unfortunately, many hospitals in the United States have removed urinalysis equipment from their wards and clinics. Our data suggest a potential reason for maintaining the ability to examine urine at the bedside.
Dr. Arruda: Section of Nephrology, University of Illinois at Chicago, 820 South Wood Street, M/C 793, Chicago, IL 60612.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987; 31:673-89.
2. Winocour PH. Microalbuminuria [Editorial]. BMJ. 1992; 304:1196-7.
3. Tai J, Tze WJ. Evaluation of Micro-Buminitest reagent tablets for screening of microalbuminuria. Diabetes Res Clin Pract. 1990; 9:137-42.
4. Kutter D, Thoma J, Kremer A, Hansen S, Carl R. Screening for oligoalbuminuria by means of Micral-Test II. A new immunological test strip. Eur J Clin Chem Clin Biochem. 1995; 33:243-5.
5. de Grauw WJ, van de Lisdonk EH, van de Hoogen HJ, van Gerwen WH, van den Bosch WJ, Willems JL, et al. Screening for microalbuminuria in type 2 diabetic patients: the evaluation of a dipstick test in general practice. Diabet Med. 1995; 12:657-63.
6. Tiu SC, Lee SS, Cheng MW. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care. 1993; 16:616-20.
7. Le Floch JP, Charles MA, Philippon C, Perlemuter L. Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients. Diabet Med. 1993; 11:349-56.
8. Marshall SM, Shearing PA, Alberti KG. Micral-test strips evaluated for screening for albuminuria. Clin Chem. 1992; 38:588-91.
9. Hasslacher C. Clinical significance of microalbuminuria and evaluation of the Micral-Test. Clin Biochem. 1993; 26:283-7.
10. Silver A, Dawnay A, Landon J, Cattel WR. Immunoassays for low concentrations of albumin in urine. Clin Chem. 1986; 32:1303-6.
11. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985-86; 9:85-95.
12. Eshoj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med. 1987; 4:531-3.
13. Johnston J, Paterson KR, O'Reilly DS. Estimating urinary albumin excretion rate of diabetic patients in clinical practice. BMJ. 1993; 306:493-4.
14. Hutchison SA, O'Reilly DS, MacCuish AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem. 1988; 34:2019-21.
15. Cowell CT, Rogers S, Silink M. First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes. Diabetologia. 1986; 29:97-9.
16. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ. 1993; 306:1722-5.
17. Gyure WL. Comparison of several methods for semiquantitative determination of urinary protein. Clin Chem. 1977; 23:876-9.
18. Meyer NL, Mercer BM, Friedman SA, Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol. 1994; 170:137-41.
19. Bashyam MM, O'Sullivan NJ, Baker HH, Duggan PF, Mitchell TH. Microalbuminuria in NIDDM. Diabetes Care. 1993; 16:634-5.
This article has been cited by other articles:
![]() |
Y. Luo, M. Chen, Q. Wen, M. Zhao, B. Zhang, X. Li, F. Wang, Q. Huang, C. Yao, T. Jiang, et al. Rapid and Simultaneous Quantification of 4 Urinary Proteins by Piezoelectric Quartz Crystal Microbalance Immunosensor Array Clin. Chem., December 1, 2006; 52(12): 2273 - 2280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Redon Measurement of microalbuminuria - what the nephrologist should know Nephrol. Dial. Transplant., March 1, 2006; 21(3): 573 - 576. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||